来自MSN1 个月
SAB BIO announces positive topline Phase 1 clinical results with potentially disease ...
The study met its primary objectives related to safety and pharmacodynamic activity enabling SAB-142 to advance to Phase 2b clinical development. “I am particularly excited with the analysis of ...
GlobalData on MSN14 天
Vir enrols first subject in Phase III programme to assess CHD therapy
The programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...